Biotech

All Articles

Viridian eye disease stage 3 hits, progressing push to rivalrous Amgen

.Viridian Rehabs' stage 3 thyroid eye health condition (TED) scientific trial has struck its own mai...

Bain unveils $3B fund for life science companies

.With a strong track record for identifying rough diamonds, Bain Funds Life Sciences (BCLS) has actu...

Genentech's cancer restructure created 'for scientific reasons'

.The current decision to combine Genentech's two cancer cells divisions was made for "scientific exp...

Tern oral GLP-1 presents 5% weight management at 1 month at best dosage

.Terns Pharmaceuticals' selection to fall its liver illness aspirations might yet repay, after the b...

Merck, Daiichi loyal very early excellence in little tissue bronchi cancer cells with upgraded ADC records

.Merck &amp Co.'s long-running attempt to land a strike on little tissue lung cancer (SCLC) has actu...

Boehringer, Bayer development bronchi cancer medicines towards Astra fight

.Some people along with non-small cell lung cancer (NSCLC) possess anomalies in a genetics named ind...

MBX tries for $136M IPO to take rival to Ascendis in to phase 3

.MBX has actually expanded plans to absorb over $136 thousand coming from its own IPO as the biotech...

Relay breast cancer cells records tee up clash with AstraZeneca's Truqap

.Relay Rehabs has actually beaten its survival goal in a first-in-human bosom cancer cells study, se...

AZ details AI-enabled TROP2 biomarker approach for Daiichi ADC

.AstraZeneca has made use of artificial intelligence to develop an unique biomarker for its own Daii...

AstraZeneca IL-33 drug stops working to improve COPD breathing in ph. 2

.AstraZeneca execs state they are "certainly not stressed" that the breakdown of tozorakimab in a pe...